Lexaria Bioscience Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
7
- Stock Symbol
-
LEXX
- Investments
-
3
- Share Price
-
$4.31
- (As of Tuesday Closing)
Lexaria Bioscience General Information
Description
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
Contact Information
Website
www.lexariabioscience.comCorporate Office
- 740 McCurdy Road
- Suite 100
- Kelowna, British Columbia V1X 2P7
- Canada
Corporate Office
- 740 McCurdy Road
- Suite 100
- Kelowna, British Columbia V1X 2P7
- Canada
Lexaria Bioscience Timeline
Lexaria Bioscience Stock Performance
As of 17-Nov-2026, Lexaria Bioscience’s stock price is $4.31. Its current market cap is $8.81M with 2.11M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.31 | $4.44 | $2.43 - $21.60 | $8.81M | 2.11M | 72.9K | -$5.10 |
Lexaria Bioscience Financials Summary
As of 31-May-2026, Lexaria Bioscience has a trailing 12-month revenue of $194K.
|
In Thousands, USD |
TTM 31-May-2026 | FY 2025 31-Aug-2025 | FY 2024 31-Aug-2024 | FY 2023 31-Aug-2023 |
|---|---|---|---|---|
| EV | 9,355 | 12,324 | 53,079 | 4,883 |
| Revenue | 194 | 706 | 464 | 226 |
| EBITDA | (7,665) | (11,827) | (5,747) | (6,610) |
| Net Income | (7,732) | (11,902) | (5,795) | (6,665) |
| Total Assets | 4,781 | 4,175 | 8,868 | 3,084 |
| Total Debt | 87 | 109 | 137 | 164 |
Lexaria Bioscience Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lexaria Bioscience Signals
Lexaria Bioscience Investments & Acquisitions (3)
Lexaria Bioscience’s most recent deal was a Secondary Transaction - Private with Poviva Tea for . The deal was made on 25-Oct-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Poviva Tea | 25-Oct-2017 | Secondary Transaction - Private | Buildings and Property | ||
| Ambarii Trade | 10-Apr-2017 | Joint Venture | Drug Discovery | ||
| Poviva Tea | 12-Dec-2014 | Merger/Acquisition | Buildings and Property |
Lexaria Bioscience ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
44.77 | Severe Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Lexaria Bioscience FAQs
-
When was Lexaria Bioscience founded?
Lexaria Bioscience was founded in 2004.
-
Where is Lexaria Bioscience headquartered?
Lexaria Bioscience is headquartered in Kelowna, Canada.
-
What is the size of Lexaria Bioscience?
Lexaria Bioscience has 7 total employees.
-
What industry is Lexaria Bioscience in?
Lexaria Bioscience’s primary industry is Other Healthcare Technology Systems.
-
Is Lexaria Bioscience a private or public company?
Lexaria Bioscience is a Public company.
-
What is Lexaria Bioscience’s stock symbol?
The ticker symbol for Lexaria Bioscience is LEXX.
-
What is the current stock price of Lexaria Bioscience?
As of 17-Nov-2026 the stock price of Lexaria Bioscience is $4.31.
-
What is the current market cap of Lexaria Bioscience?
The current market capitalization of Lexaria Bioscience is $8.81M.
-
What is Lexaria Bioscience’s current revenue?
The trailing twelve month revenue for Lexaria Bioscience is $194K.
-
What is Lexaria Bioscience’s annual earnings per share (EPS)?
Lexaria Bioscience’s EPS for 12 months was -$5.10.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process